| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $449.5M | +20.3% |
| R&D Expense | $373.8M | +42.0% |
| SG&A Expense | $164.0M | -20.7% |
| Operating Income | -$544.4M | -32.5% |
| Interest Expense | $2.6M | +0.0% |
| Pre-tax Income | -$653.4M | -70.0% |
| Income Tax | $1.1M | +279.7% |
| Net Income | -$654.6M | -70.1% |
| EPS (Basic) | -$6.41 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $141.6M | -71.2% |
| Short-term Investments | $869.6M | +97.4% |
| Accounts Receivable | $97.3M | -0.4% |
| Inventory | $51.6M | +68.2% |
| Current Assets | $1.19B | +7.0% |
| Total Assets | $1.61B | -27.0% |
| Current Liabilities | $193.2M | -0.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$309.5M | -48.1% |
| Capital Expenditures | $77.5M | +3.2% |
| Investing Cash Flow | $149.8M | +337.2% |
| Financing Cash Flow | -$189.1M | -183.0% |
| Free Cash Flow | -$386.9M | -36.2% |
| -60.3% |
| EPS (Diluted) | -$6.41 | -60.3% |
| Total Liabilities |
| $1.55B |
| -0.6% |
| Stockholders' Equity | $60.2M | -90.7% |